Exon-skipping therapies for DMD in Kazakhstan: Progress and challenges
Background Duchenne muscular dystrophy (DMD) progression has been evaluated in clinical trials; however, some ethnic populations—including Kazakhstan, a country with a genetically unique population—are still underrepresented. While the prevalence of DMD in Kazakhstan has yet to be reported, Kazakhstan is one of the onl...